The iFuse is a titanium implant coated with a porous plasma spray acting as an interference surface fit to decrease implant motion. SI-BONE received original clearance in November 2008 from the FDA to market iFuse and an updated clearance in April 2011 for additional conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The CE mark for European commercialization was obtained in November 2010.
SI-BONE Announces More Than 3K Patients Treated With iFuseWritten by Jaimie Oh | July 10, 2012
SI-BONE, a medical device company that focuses on the development of minimally invasive surgical devices, announced today more than 3,000 patients have been implanted with its iFuse Implant System.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.